Quest Diagnostics (DGX) FCF Margin (2009 - 2026)
Quest Diagnostics' (DGX) quarterly FCF Margin came in at 15.08% in Q2 2026, down 71.0% year-over-year from 52.01% in Q2 2025, and up 166.27% quarter-over-quarter from 5.66% in Q1 2026.
Powered by 
Analysis
Quest Diagnostics (DGX) FCF Margin (2009 - 2026) Analysis & Trends
Quest Diagnostics has disclosed FCF Margin across 18 years of filings, most recently posting 15.08% for Q2 2026.
- In Q2 2026, FCF Margin fell 71.0% year-over-year to 15.08%; the TTM figure through Jun 2026 stood at 11.67% (up 4.0% YoY), while the FY2025 annual figure was 12.32%, up 311.0% from the prior year.
- FCF Margin came in at 15.08% for Q2 2026 at Quest Diagnostics, up from 5.66% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 19.89% in Q4 2023 to a low of 1.42% in Q1 2023.
- Average FCF Margin over 5 years is 10.91%, with a median of 12.1% recorded in 2024.
- The largest YoY upside for FCF Margin was 1187 bps in 2023 against a maximum downside of 1739 bps in 2023.
- Over 5 years, FCF Margin stood at 8.02% in 2022, then surged by 148 bps to 19.89% in 2023, then tumbled by 35 bps to 13.01% in 2024, then fell by 16 bps to 10.94% in 2025, then surged by 38 bps to 15.08% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 15.08% in Q2 2026, 5.66% in Q1 2026, and 10.94% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | -1.15% |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 15.08% |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 8.41% |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | -20.76% |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | -3.57% |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 2.43% |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 13.08% |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 4.65% |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | -10.60% |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 16.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.08% |
| Mar 31, 2026 | 5.66% |
| Dec 31, 2025 | 10.94% |
| Sep 30, 2025 | 14.88% |
| Jun 30, 2025 | 15.79% |
| Mar 31, 2025 | 7.43% |
| Dec 31, 2024 | 13.01% |
| Sep 30, 2024 | 10.05% |
| Jun 30, 2024 | 11.18% |
| Mar 31, 2024 | 2.11% |
| Dec 31, 2023 | 19.89% |
| Sep 30, 2023 | 4.44% |
| Jun 30, 2023 | 14.54% |
| Mar 31, 2023 | -1.42% |
| Dec 31, 2022 | 8.02% |
| Sep 30, 2022 | 15.45% |
| Jun 30, 2022 | 13.29% |
| Mar 31, 2022 | 15.97% |
| Dec 31, 2021 | 12.28% |
| Sep 30, 2021 | 17.02% |